Ignite Creation Date:
2025-12-24 @ 5:44 PM
Ignite Modification Date:
2025-12-28 @ 12:55 AM
Study NCT ID:
NCT05170568
Status:
UNKNOWN
Last Update Posted:
2022-11-01
First Post:
2021-12-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PA3-17 Injection Treatment of Adult Patients With CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
Sponsor:
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-12-24
First Submit QC Date:
None
Study First Post Date:
2021-12-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-31
Last Update Post Date:
2022-11-01
Last Update Post Date Type:
ACTUAL